About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
More or Less? Impact of Dose Number on Outcomes of Patients w/ ALL Treated with Inotuzumab Ozogamicin
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Elias Jabbour
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Elias Jabbour
36 views
November 18, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Acute Lymphoblastic Leukemia
14:35
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Moving Beyond Single Antigen CAR-T Targeting in ALL: Current Status …
Feat.
N. Shah
12:05
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Is HCT Still Needed in the Era of Targeted Cellular Therapies for Ac…
Feat.
P. Kebriaei
14:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Is HCT Still Necessary in the Era of Targeted Cellular Therapy for A…
Feat.
M. Pulsipher
14:38
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Combining Genotype Profiling with MRD for More Accurate Prognosticat…
Feat.
J. Bartram
15:09
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Ph+ ALL: How Can We Optimize Treatment for All Patients Through Bett…
Feat.
S. Chiaretti
04:11
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Management of Adult ALL: Which Chemo Intensity, Further Progress Wit…
Feat.
D. Hoelzer
12:37
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Novel Therapies in Older Patients with Ph- B-Cell ALL: Older ALL, Po…
Feat.
E. Jabbour
14:53
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
The Challenge of Improving Outcomes for ETP ALL and Relapsed Disease…
Feat.
B. Shah
09:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Duplex Sequencing Identifies Low Level ABL1 Kinase Domain Mutations …
Feat.
N. Short
07:55
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
More or Less? Impact of Dose Number on Outcomes of Patients w/ ALL T…
Feat.
E. Jabbour
